68Ga-FAPI-46 PET/CT衍生参数对多种实体瘤总生存期的预后意义
研究纳入两项前瞻性影像研究的145例患者,在4周内行68Ga-FAPI-46与18F-FDG PET/CT,采用Cox回归分析总生存期与各参数的关系。单因素分析显示两种显像的总病灶数及淋巴结、内脏、骨转移均与较短总生存期相关,多因素分析中仅68Ga-FAPI-46 PET/CT总病灶数为独立危险因素。作者认为68Ga-FAPI-46 PET/CT的病变范围可预测较短总生存期,并可能作为18F-FDG PET/CT的补充用于未来风险分层。
要点
- 68Ga-FAPI-46 PET/CT总病灶数为较短总生存期的独立危险因素(HR 1.05,P=0.02)。
- 单因素分析中两种显像的淋巴结、内脏、骨转移均与较短总生存期相关。
- 胰腺癌中68Ga-FAPI-46 PET/CT总病灶数在多因素分析中与较短总生存期相关(HR 1.07,P=0.04)。
核心结论
- 68Ga-FAPI-46 PET/CT所示病变范围是较短总生存期的预测因素,可能作为18F-FDG PET/CT的补充在未来风险分层中发挥作用。
研究设计与样本
- 研究纳入两项前瞻性影像研究(NCT05160051,n=30;NCT04571086,n=115)共145例患者,在4周内行68Ga-FAPI-46与18F-FDG PET/CT,采用单因素及多因素Cox回归分析总生存期与性别、年龄、肿瘤类型、总病灶数、最高SUVmax及淋巴结、内脏、骨转移的关系。
主要发现
- 单因素分析中,68Ga-FAPI-46 PET/CT总病灶数及淋巴结、内脏、骨转移与较短总生存期相关(HR分别为1.06、2.18、1.69、2.05;P分别<0.01、<0.01、=0.04、=0.02)。
- 单因素分析中,18F-FDG PET/CT总病灶数及淋巴结、内脏、骨转移与较短总生存期相关(HR分别为1.05、2.31、1.76、2.30;P分别<0.01、<0.01、=0.03、<0.01)。
- 单因素分析中,68Ga-FAPI-46 PET/CT的SUVmax与较短总生存期相关(HR 1.03;P=0.03)。
- 多因素分析中,68Ga-FAPI-46 PET/CT总病灶数是较短总生存期的独立危险因素(HR 1.05;P=0.02)。
- 胰腺癌患者中,单因素分析显示68Ga-FAPI-46 PET/CT总病灶数(HR 1.09;P<0.01)和18F-FDG PET/CT骨转移(HR 31.39;P<0.01)与较短总生存期相关,多因素分析显示68Ga-FAPI-46 PET/CT总病灶数(HR 1.07;P=0.04)与较短总生存期相关。
临床怎么用
- 作者认为68Ga-FAPI-46 PET/CT所示病变范围可预测较短总生存期,并可能作为18F-FDG PET/CT的补充在未来风险分层中发挥作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tumoral fibroblast activation protein expression is associated with proliferation and angiogenesis and can be visualized by PET/CT. We examined the prognostic value of [68Ga]Ga-fibroblast activation protein inhibitor (FAPI) (68Ga-FAPI)-46 PET/CT for different tumor entities in patients enrolled in 2 prospective imaging studies (NCT05160051, n = 30; NCT04571086, n = 115). Methods: Within 4 wk, 145 patients underwent 68Ga-FAPI-46 and [18F]FDG (18F-FDG) PET/CT. The association between overall survival (OS) and sex, age, tumor entity, total lesion number, highest SUVmax, and the presence of each nodal, visceral, and bone metastasis was tested using univariate Cox regression analysis. Multivariate analyses were performed for prognostic factors with P values of less than 0.05. Results: In the univariate analysis, shorter OS was associated with total lesion number and the presence of nodal, visceral, and bone metastases on 68Ga-FAPI-46 PET/CT (hazard ratio [HR], 1.06, 2.18, 1.69, and 2.05; P < 0.01, < 0.01, = 0.04, and = 0.02, respectively) and 18F-FDG PET/CT (HR, 1.05, 2.31, 1.76, and 2.30; P < 0.01, < 0.01, = 0.03, and < 0.01, respectively) and with SUVmax on 68Ga-FAPI-46 PET/CT (HR, 1.03; P = 0.03). In the multivariate analysis, total lesion number on 68Ga-FAPI-46 PET/CT was an independent risk factor for shorter OS (HR, 1.05; P = 0.02). In patients with pancreatic cancer, shorter OS was associated with total lesion number on 68Ga-FAPI-46 PET/CT (HR, 1.09; P < 0.01) and bone metastases on 18F-FDG PET/CT (HR, 31.39; P < 0.01) in the univariate analysis and with total lesion number on 68Ga-FAPI-46 PET/CT (HR, 1.07; P = 0.04) in the multivariate analyses. In breast cancer, total lesion number on 68Ga-FAPI-46 PET/CT (HR, 1.07; P = 0.02), as well as bone metastases on 18F-FDG PET/CT (HR, 9.64; P = 0.04), was associated with shorter OS in the univariate analysis. The multivariate analysis did not reveal significant prognostic factors. In thoracic cancer (lung cancer and pleural mesothelioma), the univariate and multivariate analyses did not reveal significant prognostic factors. Conclusion: Disease extent on 68Ga-FAPI-46 PET/CT is a predictor of short OS and may aid in future risk stratification by playing a supplemental role alongside 18F-FDG PET/CT.
引用
- Watanabe M, Fendler WP, Grafe H, et al. Prognostic Implications of 68Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors. J Nucl Med. 2024. PMID: 38782454. doi:10.2967/jnumed.123.266981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。